Keang Suy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Keang Suy has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Arjun Chandna
Affiliations Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia, Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, United Kingdom, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, United Kingdom
1 shared publication- Arjun Chandna
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
1 shared publication Bui Thanh Liem
University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam
1 shared publication- Chris Painter
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK
1 shared publication Clare L. Ling
Affiliations Cambodia Oxford Medical Research Unit, Angkor Hospital for Children, Siem Reap, Cambodia, Centre for Tropical Medicine & Global Health, University of Oxford, Oxford, United Kingdom
1 shared publication- Constantinos Koshiaris
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 29 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1907-1916
Predicting referral need for febrile children in low-resource community settings in South and Southeast Asia
In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.
- 29 April 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (5) , 1907-1916
Open AccessPredicting referral need for febrile children in low-resource community settings in South and Southeast Asia
In resource-constrained community settings, identifying which febrile children require referral remains a major unmet need. Current World Health Organization (WHO) danger signs have limited accuracy, resulting in missed severe illness and unnecessary referrals. Here we developed and validated clinical prediction models to support referral decisions using data from 3,405 children aged 1−59 months presenting with community-acquired acute febrile illnesses to seven hospitals across Bangladesh, Cambodia, Indonesia, Laos and Vietnam. Cambodian data were held out for external validation. The model using simple clinical parameters (sensitivity 74.7% (95% confidence interval (CI): 59.4−88.1); specificity 99.1% (95% CI: 97.7−99.7)) outperformed WHO criteria (sensitivity 55.5% (95% CI: 39.4−72.7); specificity 82.6% (95% CI: 77.1−87.6)) for identification of children at risk of severe disease (death or organ support within 2 days). Including either pulse oximetry or the host biomarker soluble TREM1 (sTREM1) increased sensitivity to 88.9% (95% CI: 76.7−97.8; pulse oximetry) and 89.2% (95% CI: 76.9−97.5; sTREM1), respectively. The pulse oximetry-based model achieved these gains with a threefold reduction in referral rates. These approaches appear cost-effective (pulse oximetry incremental cost effectiveness ratio (ICER) = $26.28; sTREM1 ICER = $196.46) and could improve triage for febrile illness in low-resource settings by enabling more accurate referral decisions. They warrant evaluation in community-based trials.
- Open Access
- 3 February 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (2) , e0013962
Rapid diagnosis of skin and soft tissue melioidosis in children
Melioidosis is an endemic infection caused by Burkholderia pseudomallei , found in tropical and subtropical regions. In resource-limited settings, culture-based diagnostics are often slow, delaying appropriate treatment, or unavailable. We conducted an interventional ambispective cohort study to assess the impact and diagnostic accuracy of the Active Melioidosis Detect Plus rapid diagnostic test (AMD-RDT) in Cambodian children with suspected skin and soft tissue melioidosis (SST-M). The retrospective cohort (July 2022–July 2023) received standard diagnostics; the prospective cohort (July 2023–December 2024) included AMD-RDT testing. Twenty-five retrospective culture-confirmed participants and 107 participants (31 culture-confirmed) in the prospective arm were analysed. Median time from pus collection to appropriate antibiotic initiation was 118.4 hours in the retrospective arm and 14.4 hours in the prospective arm (p = 0.057). Disseminated melioidosis workups were completed for 24% (6/25) and 80.6% (25/31) of retrospective and prospective participants respectively (p < 0.001), and detected two children with bacteraemia and three with intra-abdominal abscesses in the prospective arm. The AMD-RDT achieved a sensitivity of 90.3% (95% CI: 74.2–98.0%), specificity of 100% (95% CI: 95.3–100%), and an area under the receiver operating characteristic curve (AUC) of 0.95 (95% CI 0.89-1.00). Incorporating the AMD-RDT into the routine diagnostic pathway was associated with a reduction in time to effective antibiotic therapy and an increase in the proportion of participants completing a comprehensive diagnostic workup for systemic involvement. The high accuracy and rapid turnaround time support its use in resource-limited settings.
- 3 February 2026
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 20 (2) , e0013962
Open AccessRapid diagnosis of skin and soft tissue melioidosis in children
Melioidosis is an endemic infection caused by Burkholderia pseudomallei , found in tropical and subtropical regions. In resource-limited settings, culture-based diagnostics are often slow, delaying appropriate treatment, or unavailable. We conducted an interventional ambispective cohort study to assess the impact and diagnostic accuracy of the Active Melioidosis Detect Plus rapid diagnostic test (AMD-RDT) in Cambodian children with suspected skin and soft tissue melioidosis (SST-M). The retrospective cohort (July 2022–July 2023) received standard diagnostics; the prospective cohort (July 2023–December 2024) included AMD-RDT testing. Twenty-five retrospective culture-confirmed participants and 107 participants (31 culture-confirmed) in the prospective arm were analysed. Median time from pus collection to appropriate antibiotic initiation was 118.4 hours in the retrospective arm and 14.4 hours in the prospective arm (p = 0.057). Disseminated melioidosis workups were completed for 24% (6/25) and 80.6% (25/31) of retrospective and prospective participants respectively (p < 0.001), and detected two children with bacteraemia and three with intra-abdominal abscesses in the prospective arm. The AMD-RDT achieved a sensitivity of 90.3% (95% CI: 74.2–98.0%), specificity of 100% (95% CI: 95.3–100%), and an area under the receiver operating characteristic curve (AUC) of 0.95 (95% CI 0.89-1.00). Incorporating the AMD-RDT into the routine diagnostic pathway was associated with a reduction in time to effective antibiotic therapy and an increase in the proportion of participants completing a comprehensive diagnostic workup for systemic involvement. The high accuracy and rapid turnaround time support its use in resource-limited settings.